http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017161473-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bfdf49224a405be1f7b653c56ebad94 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44 |
| filingDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da53bce61dc92dbc2c07cf9b7c1485b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145861417d068e2da5c6e6c566ce887b |
| publicationDate | 2017-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017161473-A |
| titleOfInvention | Test method and test drug for heart disease etc. by autotaxin measurement |
| abstract | Disclosed are a test method and a test drug for the discovery of chronic heart disease, diagnosis of the degree thereof, and particularly a disease caused by cardiac dysfunction. The autotaxin concentration in a human specimen (eg, blood component) is measured by, for example, an immunochemical method using an antibody against autotaxin, and chronic heart disease (eg, congestive heart failure, dilated cardiomyopathy, etc.) Heart failure, brain natriuretic peptide (BNP) in serum, heart failure requiring treatment showing a concentration of 200 pg / mL or more) and congestive liver. [Selection] Figure 2 |
| priorityDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.